36Kr's 15min chart: Bollinger Bands narrowing, KDJ death cross triggered.

Based on the 15-minute chart of 36Kr, the Bollinger Bands have narrowed, indicating a decrease in the magnitude of stock price fluctuations. Additionally, the KDJ indicator has formed a death cross at 10/07/2025 15:30, suggesting that the momentum of the stock price is shifting towards the downside and may continue to decrease.

Galecto Inc (GLTO) has seen significant volatility in its stock price over recent months, with the stock trading at a 52-week low of $3.76 as of March 19, 2025. According to the latest data from Investing.com Galecto Inc (GLTO)^[1], the stock's price has fluctuated widely, with a 52-week range of $2.01 to $26.21. The stock's market capitalization stands at $4.91 million, with 1.32 million shares outstanding.

The 15-minute chart of 36Kr indicates that the Bollinger Bands have narrowed, suggesting a decrease in the magnitude of stock price fluctuations. This narrowing of the Bands could imply that the stock's price is stabilizing after a period of high volatility. However, the recent formation of a death cross by the KDJ indicator on October 7, 2025, at 15:30, signals a potential shift in the stock's momentum towards the downside . The death cross, formed by the K line crossing below the D line, typically indicates a bearish trend.

Galecto Inc's financial health is assessed by its market value, financial ratios, and industry benchmarks. According to the GLTO Scorecard on Investing.com, the company holds more cash than debt on its balance sheet and has a fair value estimate based on valuation models. However, the stock's current price-to-earnings ratio is -0.28, indicating that the company is not currently profitable. The company's return on assets and return on equity are also negative, suggesting that it is not generating sufficient profits to cover its costs .

Galecto Inc is a clinical-stage biotechnology company focused on the development of molecule therapeutics for the treatment of fibrosis, cancer, inflammation, and other related diseases. The company's stock has been affected by market challenges and a tough environment for biotechnology firms. The recent decline in the stock price may be attributed to these factors, as well as the company's strategic focus on oncology and liver diseases.

In conclusion, while the narrowing of the Bollinger Bands suggests a potential stabilization in Galecto Inc's stock price, the formation of a death cross by the KDJ indicator indicates a potential bearish trend. Investors should carefully consider these signals and the company's financial health before making investment decisions. Further analysis and monitoring of the stock's performance and market conditions are recommended.